1-3 of 3
active ulcerative colitis trial
Close
Sort by
Journal Articles

First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy

Francesco d'Amore, Sirpa Leppä, Maria Gomes da Silva, Thomas Relander, Peter De Nully Brown, Eckhart Weidmann, Grete Fossum Lauritzsen, Antonio Pezzutto, Achiel Van Hoof, Michel van Gelder, Jeanette K Doorduijn, Ka Lung Wu, MD, PhD, J.C. Kluin-Nelemans, P.J. Lugtenburg, Milada Jankovska, Mats Merup, Unn-Merete Fagerli, Jan Walewski, Hans Hagberg, Jose Mario Mariz, Per Boye Hansen, Thomas Nösslinger, Ann Janssens, Lena Brandefors, Hilde Demuynck, Martyn Ronald Schaafsma, Ilse Christiansen, David Salek, Sirkku Jyrkkiö, Vit Prochazka, Josee Zijlstra, L. Böhmer, Richard Greil, MD, Wendy Stevens, Rob Fijnheer, Marinus van Marwijk Kooy, Matthias Grube, Georg Hopfinger, MD, Eric Van den Neste, Esa Jantunen, Lorenz Trümper, Gerald Wulf, Bettina Altmann, Marita Ziepert, Markus Loeffler, Helle Toldbod
Journal: Blood
Blood (2012) 120 (21): 57.
https://doi.org/10.1182/blood.V120.21.57.57
Published: 2012
Journal Articles

First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant,

Francesco d'Amore, MD, DMSci, Maria Gomes da Silva, Sirpa Leppa, Thomas Relander, Antonio Pezzutto, Grete F. Lauritzsen, Eckhart Weidmann, Michel Van Gelder, Mats Merup, Hans Hagberg, Unn-Merete Fagerli, Peter de Nully Brown, Per Boye Hansen, Jose Mario Mariz, Milada Jankovska, Jan Walewski, MD, PhD, Jeanette Doorduijn, Achiel Van Hoof, Ilse Christiansen, Sirkku Jyrkkiö, J.C. Kluin-Nelemans, Marinus van Marwijk Kooy, Rob Fijnheer, Wendy Stevens, Josee Zijlstra, L. Böhmer, P.J. Lugtenburg, Matthias Grube, Vit Prochazka, David Salek, Richard Greil, MD, Lorenz Trümper, Gerald Wulf, Bettina Altmann, Marita Ziepert, Markus Loeffler, Esa Jantunen, Georg Hopfinger, Eric Van den Neste, MD, Helle Toldbod
Journal: Blood
Blood (2011) 118 (21): 4110.
https://doi.org/10.1182/blood.V118.21.4110.4110
Published: 2011
Journal Articles

Sufficient and Timely Autologous Stem Cell Harvest After Chemoimmunotherapy with Alemtuzumab In Combination with Bi-Weekly CHOP as First Line Treatment In Systemic Peripheral T-Cell Lymphomas (PTCL): a Feasibility Analysis From the First Randomized Trial In Systemic PTCL (ACT trial)

Francesco d'Amore, Maria Gomes da Silva, Sirpa Leppa, Antonio Pezzutto, Thomas Relander, Grete Fossum Lauritzsen, Eckhart Weidmann, Michel Van Gelder, Jeanette Doorduijn, J.C. Kluin-Nelemans, Marinus van Marwijk Kooy, Rob Fijnheer, Okke de Weerdt, Peter de Nully Brown, Per Boye Hansen, Mats Merup, Matthias Grube, Jose Mario Mariz, Jan Walewski, Lorenz Truemper, Gerald Wulf, Esa Jantunen, Georg Hopfinger, it Prochazka, V
Journal: Blood
Blood (2010) 116 (21): 2395.
https://doi.org/10.1182/blood.V116.21.2395.2395
Published: 2010